Gerasimos Bastas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Gerasimos Bastas has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Eric C. Honert
Human Performance Laboratory, Department of Kinesiology, University of Calgary, Calgary, AB T2N 1N4, Canada
2 shared publications Karl E. Zelik
Dept. of Mechanical Engineering, Vanderbilt University, Nashville, TN, USA; Dept. of Physical Medicine & Rehabilitation, Vanderbilt University, Nashville, TN, USA; Dept. of Biomedical Engineering, Vanderbilt University, Nashville, TN, USA
2 shared publicationsKodela Vani
2 shared publicationsSeshi R. Sompuram
2 shared publications- Steven A. Bogen
Medical Discovery Partners LLC, USA
2 shared publications Adrian Popescu
1 shared publication
Latest Publications
- 1 April 2020
- Published by Elsevier in Human Movement Science
- Vol. 70, 102594
Effects of toe length, foot arch length and toe joint axis on walking biomechanics
- 1 April 2020
- Published by Elsevier in Human Movement Science
- Vol. 70, 102594
Effects of toe length, foot arch length and toe joint axis on walking biomechanics
- 1 November 2018
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
- Vol. 97 (11) , e104-e106
Femoral Artery Bypass Graft Pseudoaneurysm Rupture in a Transfemoral Amputee
We describe the case of a patient with an actively bleeding pseudoaneurysm associated with remnants of a polytetrafluoroethylene (PTFE) femoral bypass graft in their transfemoral residual limb. Initial graft placement was due to peripheral arterial disease. During subsequent transfemoral amputation, remnants of the non-patent graft were retained in the residuum. Following four years of lower limb prosthesis use, a proximal anastomosis pseudoaneurysm developed (with avulsion of graft remnants). The patient presented to clinic with a 5-day history of increased left groin fullness and largely non-radiating pain (rated 10/10). He was diagnosed with a pseudoaneurysm (1.9 cm) originating from the left common femoral artery and an associated hematoma (8 cm) on CT; this required emergent reoperation. This case highlights the importance surrounding the decision to leave or explant neovascularization materials, which may carry significant risk for infection or physical disruption complications in residual limbs.
- 1 November 2018
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
- Vol. 97 (11) , e104-e106
Femoral Artery Bypass Graft Pseudoaneurysm Rupture in a Transfemoral Amputee
We describe the case of a patient with an actively bleeding pseudoaneurysm associated with remnants of a polytetrafluoroethylene (PTFE) femoral bypass graft in their transfemoral residual limb. Initial graft placement was due to peripheral arterial disease. During subsequent transfemoral amputation, remnants of the non-patent graft were retained in the residuum. Following four years of lower limb prosthesis use, a proximal anastomosis pseudoaneurysm developed (with avulsion of graft remnants). The patient presented to clinic with a 5-day history of increased left groin fullness and largely non-radiating pain (rated 10/10). He was diagnosed with a pseudoaneurysm (1.9 cm) originating from the left common femoral artery and an associated hematoma (8 cm) on CT; this required emergent reoperation. This case highlights the importance surrounding the decision to leave or explant neovascularization materials, which may carry significant risk for infection or physical disruption complications in residual limbs.
- 10 October 2018
- Published by IOP Publishing in Bioinspiration & Biomimetics
- Vol. 13 (6) , 066007
Effect of toe joint stiffness and toe shape on walking biomechanics
During typical human walking, the metatarsophalangeal joints undergo extension/flexion, which we term toe joint articulation. This toe joint articulation impacts locomotor performance, as evidenced by prior studies on prostheses, footwear, sports and humanoid robots. However, a knowledge gap exists in our understanding of how individual toe properties (e.g. shape, joint stiffness) affect bipedal locomotion. To address this gap, we designed and built a pair of adjustable foot prostheses that enabled us to independently vary different toe properties, across a broad range of physiological and non-physiological values. We then characterized the effects of varying toe joint stiffness across a range of different ankle joint stiffness conditions, and the effects of varying toe shape on walking biomechanics. Ten able-bodied individuals walked on a treadmill with prostheses mounted bilaterally underneath simulator boots (which immobilized their biological ankles). We collected motion capture and ground reaction force data, then computed joint kinematics and kinetics, and center-of-mass (COM) power and work. To our surprise, we found that varying toe joint stiffness affected COM Push-off dynamics during walking as much as, or in some cases even more than, varying ankle joint stiffness. Increasing toe joint stiffness increased COM Push-off work by up to 48% (6 J), and prosthetic anklefoot Push-off work by up to 181% (12 J). In contrast, large changes in toe shape had little effect on gait. This study brings attention to the toes, an aspect of prosthetic and robotic foot design that is often overlooked or overshadowed by design of the ankle. Optimizing toe joint stiffness in assistive and robotic devices (e.g. prostheses, exoskeletons, robot feet) may provide a complementary means of enhancing Push-off or other aspects of locomotor performance, in conjunction with the more conventional approach of augmenting ankle dynamics. Future studies are needed to isolate the effects of additional toe properties (e.g. toe length).
- 10 October 2018
- Published by IOP Publishing in Bioinspiration & Biomimetics
- Vol. 13 (6) , 066007
Effect of toe joint stiffness and toe shape on walking biomechanics
During typical human walking, the metatarsophalangeal joints undergo extension/flexion, which we term toe joint articulation. This toe joint articulation impacts locomotor performance, as evidenced by prior studies on prostheses, footwear, sports and humanoid robots. However, a knowledge gap exists in our understanding of how individual toe properties (e.g. shape, joint stiffness) affect bipedal locomotion. To address this gap, we designed and built a pair of adjustable foot prostheses that enabled us to independently vary different toe properties, across a broad range of physiological and non-physiological values. We then characterized the effects of varying toe joint stiffness across a range of different ankle joint stiffness conditions, and the effects of varying toe shape on walking biomechanics. Ten able-bodied individuals walked on a treadmill with prostheses mounted bilaterally underneath simulator boots (which immobilized their biological ankles). We collected motion capture and ground reaction force data, then computed joint kinematics and kinetics, and center-of-mass (COM) power and work. To our surprise, we found that varying toe joint stiffness affected COM Push-off dynamics during walking as much as, or in some cases even more than, varying ankle joint stiffness. Increasing toe joint stiffness increased COM Push-off work by up to 48% (6 J), and prosthetic anklefoot Push-off work by up to 181% (12 J). In contrast, large changes in toe shape had little effect on gait. This study brings attention to the toes, an aspect of prosthetic and robotic foot design that is often overlooked or overshadowed by design of the ankle. Optimizing toe joint stiffness in assistive and robotic devices (e.g. prostheses, exoskeletons, robot feet) may provide a complementary means of enhancing Push-off or other aspects of locomotor performance, in conjunction with the more conventional approach of augmenting ankle dynamics. Future studies are needed to isolate the effects of additional toe properties (e.g. toe length).
- 30 July 2018
- Published by ASME International in Journal of Medical Devices
- Vol. 12 (3)
Variable Geometry Stair Ascent and Descent Controller for a Powered Lower Limb Exoskeleton
This paper describes a control approach for a lower limb exoskeleton intended to enable stair ascent and descent of variable geometry staircases for individuals with paraplegia resulting from spinal cord injury (SCI). To assess the efficacy of ascent and descent functionality provided by the control approach, the controller was implemented in a lower limb exoskeleton and tested in experimental trials on three subjects with motor-complete SCI on three staircases of varying geometry. Results from the assessments indicate that subjects were able to capably ascend and descend step heights varying from 7.6 to 16.5 cm without changing control settings; the controller provided for step time consistency highly representative of healthy subjects (9.2% variation in exoskeleton step time, relative to 7.7% variation in healthy subjects); and the exoskeleton provided peak joint torques on average 110% and 74% of the healthy-subject peak joint torques during stair ascent and descent, respectively. Subject perceived exertion during the stair ascent and descent activities was rated between “light” and “very light.”
- 30 July 2018
- Published by ASME International in Journal of Medical Devices
- Vol. 12 (3)
Variable Geometry Stair Ascent and Descent Controller for a Powered Lower Limb Exoskeleton
This paper describes a control approach for a lower limb exoskeleton intended to enable stair ascent and descent of variable geometry staircases for individuals with paraplegia resulting from spinal cord injury (SCI). To assess the efficacy of ascent and descent functionality provided by the control approach, the controller was implemented in a lower limb exoskeleton and tested in experimental trials on three subjects with motor-complete SCI on three staircases of varying geometry. Results from the assessments indicate that subjects were able to capably ascend and descend step heights varying from 7.6 to 16.5 cm without changing control settings; the controller provided for step time consistency highly representative of healthy subjects (9.2% variation in exoskeleton step time, relative to 7.7% variation in healthy subjects); and the exoskeleton provided peak joint torques on average 110% and 74% of the healthy-subject peak joint torques during stair ascent and descent, respectively. Subject perceived exertion during the stair ascent and descent activities was rated between “light” and “very light.”
- 1 July 2018
- Published by Elsevier in Gait & Posture
- Vol. 64, 30-37
IMU-based gait analysis in lower limb prosthesis users: Comparison of step demarcation algorithms
- 1 July 2018
- Published by Elsevier in Gait & Posture
- Vol. 64, 30-37
IMU-based gait analysis in lower limb prosthesis users: Comparison of step demarcation algorithms
- Open Access
- 1 February 2008
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 7 (2) , 247-256
Bioinformatic Requirements for Protein Database Searching Using Predicted Epitopes from Disease-associated Antibodies
- 1 February 2008
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 7 (2) , 247-256
Open AccessBioinformatic Requirements for Protein Database Searching Using Predicted Epitopes from Disease-associated Antibodies
- 1 January 2008
- Published by American Society of Hematology in Blood
- Vol. 111 (1) , 302-308
Accurate identification of paraprotein antigen targets by epitope reconstruction
We describe the first successful clinical application of a new discovery technology, epitope-mediated antigen prediction (E-MAP), to the investigation of multiple myeloma. Until now, there has been no reliable, systematic method to identify the cognate antigens of paraproteins. E-MAP is a variation of previous efforts to reconstruct the epitopes of paraproteins, with the significant difference that it provides enough epitope sequence data so as to enable successful protein database searches. We first reconstruct the paraprotein's epitope by analyzing the peptides that strongly bind. Then, we compile the data and interrogate the nonredundant protein database, searching for a close match. As a clinical proof-of-concept, we apply this technology to uncovering the protein targets of para-proteins in multiple myeloma (MM). E-MAP analysis of 2 MM paraproteins identified human cytomegalovirus (HCMV) as a target in both. E-MAP sequence analysis determined that one para-protein binds to the AD-2S1 epitope of HCMV glycoprotein B. The other binds to the amino terminus of the HCMV UL-48 gene product. We confirmed these predictions using immunoassays and immunoblot analyses. E-MAP represents a new investigative tool for analyzing the role of chronic antigenic stimulation in B-lymphoproliferative disorders.
- 1 January 2008
- Published by American Society of Hematology in Blood
- Vol. 111 (1) , 302-308
Accurate identification of paraprotein antigen targets by epitope reconstruction
We describe the first successful clinical application of a new discovery technology, epitope-mediated antigen prediction (E-MAP), to the investigation of multiple myeloma. Until now, there has been no reliable, systematic method to identify the cognate antigens of paraproteins. E-MAP is a variation of previous efforts to reconstruct the epitopes of paraproteins, with the significant difference that it provides enough epitope sequence data so as to enable successful protein database searches. We first reconstruct the paraprotein's epitope by analyzing the peptides that strongly bind. Then, we compile the data and interrogate the nonredundant protein database, searching for a close match. As a clinical proof-of-concept, we apply this technology to uncovering the protein targets of para-proteins in multiple myeloma (MM). E-MAP analysis of 2 MM paraproteins identified human cytomegalovirus (HCMV) as a target in both. E-MAP sequence analysis determined that one para-protein binds to the AD-2S1 epitope of HCMV glycoprotein B. The other binds to the amino terminus of the HCMV UL-48 gene product. We confirmed these predictions using immunoassays and immunoblot analyses. E-MAP represents a new investigative tool for analyzing the role of chronic antigenic stimulation in B-lymphoproliferative disorders.